Cytek Biosciences (CTKB) Interest & Investment Income (2020 - 2026)
Cytek Biosciences (CTKB) posted Interest & Investment Income of $787000.0 for Q1 2026, up 35.69% on a QoQ basis from $580000.0 in Q4 2025, and up 54.92% year-over-year from $508000.0 in Q1 2025.
Cytek Biosciences (CTKB) Interest & Investment Income (2020 - 2026) Analysis & Trends
Cytek Biosciences' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $787000.0 for Q1 2026.
- Quarterly Interest & Investment Income rose 54.92% year-over-year to $787000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 41.57% YoY) and the FY2025 annual result came in at $2.2 million, down 56.73% from the prior year.
- Interest & Investment Income was $787000.0 for Q1 2026 at Cytek Biosciences, up from $580000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.6 million in Q4 2022 and bottomed at $18000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $1.2 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 14488.89% — and 2025, when it tumbled 62.62%.
- Cytek Biosciences' Interest & Investment Income stood at $2.6 million in 2022, then tumbled by 44.86% to $1.4 million in 2023, then plunged by 36.95% to $913000.0 in 2024, then sank by 36.47% to $580000.0 in 2025, then soared by 35.69% to $787000.0 in 2026.
- Business Quant data shows CTKB's Interest & Investment Income at $787000.0 in Q1 2026, $580000.0 in Q4 2025, and $573000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Cytek Biosciences | 565.66 Mn | 499.96 Mn | 21.25 Mn | 787,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 787,000.00 |
| Dec 31, 2025 | 580,000.00 |
| Sep 30, 2025 | 573,000.00 |
| Jun 30, 2025 | 555,000.00 |
| Mar 31, 2025 | 508,000.00 |
| Dec 31, 2024 | 913,000.00 |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 391,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 18,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 9,000.00 |